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1. Introduction   
Epilepsy is the most common chronic neurologic disorder in paediatric neurology and the 
predominant aetiologies are birth injury and congenital abnormalities. Epilepsy has a 
tendency to recurrent seizures. Most of these will have primary or idiopathic epilepsy (i.e., 
no underlying cause will be evident), but some will have secondary epilepsy due to a cause 
such as head injury, meningitis, or birth asphyxia. The international classification of 
epileptic seizures divides the epilepsies into those that are generalized, where the whole 
brain is involved, and the partial seizures, where the aberrant activity involves only a part of 
the brain (Koch & Poulsen, 2009). In infants, birth injuries and congenital defects are the 
primary causes of epilepsy. Birth injuries, genetic factors, infections, and trauma are major 
contributing factors in children and adolescents from 2 to 20 years of age. For individuals 
between 20 and 30 years of age, brain tumors and other structural lesions are the foremost 
contributing causes. In those older than 50 years of age, cerebral vascular accidents and 
metastatic tumors are significant causes of seizure activity (Aragon & Burneo, 2007).  
Epilepsy is the most common neurological problem of childhood, and its incidence is the 
highest in the first decade of life, a period during which children begin and complete a critical 
part of their social and educational development. Epilepsy is a common chronic neurologic 
disorder that affects 1–3% of the population, and almost 10% of the population will have one 
or more seizures at some time in their lives (Hauser et al., 1996). The epilepsies form an array 
of more or less discrete epilepsy syndromes, characterized by age of onset, hereditary factors, 
seizure types, electroencephalogram (EEG) abnormalities, and prognosis (Roger, 2005).  
A seizure is classified as “partial” when the electrical discharge causing it to occur in a 
specific area of the brain or “generalized” when the discharge affects the entire brain cortex. 
When there is loss of awareness, seizures are termed complex. The classification of epilepsy 
is similar. Epilepsy can be partial or generalized. Based on the cause, it can be symptomatic 
(caused by a developmental malformation), idiopathic (when a genetic condition is 
responsible) or cryptogenic (when the cause is unknown) (Aragon & Burneo, 2007). Epilepsy 
is the most common disorder in paediatric neurology and the predominant aetiologies are 
birth injury and congenital abnormalities.  
2. Classification of seizures 
There are five types of epilepsy, they are: 
Grand mal seizures 
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Petit mal seizures 
Psychomotor seizures 
Focal seizure (Jacksonian seizures) 
Self induced seizures (Rao, 2008). 
2.1 Grand mal seizures 
Onset is rapid and preceded by momentary aura. Associated with tonic and clonic phases of 
muscular spasm, patient losses consciousness and becomes pale. Pupils dilate, eyeballs roll 
upwards or to one side, the face becomes distorted and there is often rapid contraction of 
the jaw muscles. Micturition and defecation may occur. 
Patient may experience cyanosis during the tonic phase (continuous tension or contraction) 
lasting for 20-40 seconds. Clonic phase (alternating series of contractions and partial 
relaxation) may last for several minutes. Patient wakes up from seizure with severe 
headache and in a general state of confusion. A patient who experiences a grand mal seizure 
in the dental office should be handled conservatively and be put in a position in which he 
cannot harm himself possibly on the floor away from the dental equipment. If the seizure is 
prolonged, administration of oxygen may be necessary. A rubber or plastic mouth prop has 
to be inserted to prevent the patient from biting his tongue. A tongue blade wrapped with 
gauze and adhesive may be utilized. It is usually sufficient that the dentist wait until the 
seizure stops and then evaluate him. If the seizure is prolonged, administration of oxygen 
may be necessary. Recovery may be quick or patient may be irritable. 
2.2 Petit mal seizures 
It appears between 3 years of age and puberty. More common in girls. It consists of transient 
loss of consciousness. It may occur once or twice a month or very frequently at less intervals 
and lasting for less than 30 seconds. Other features are upward rolling of eyes, moving of 
the lids, drooling or rhythmic nodding of the head or slight quivering of the trunk and limb 
muscles. They may also go unnoticed. 
2.3 Psychomotor seizures 
They are difficult to recognize and control. Slight aura is manifested as a shrill of cry or an 
attempt to run for help. Child is often drowsy or sleeps for a short time after the spell. 
Seizure consists of loss of postural tone. 1-5 minutes of unconsciousness is followed by 
normal sleep or activity. No tonic or clonic movements present. 
2.4 Focal seizure (Jacksonian seizures) 
It is produced by injury to the brain. Seizures are clonic in nature. Muscles involved are the 
ones most specialized for voluntary movements in the hand, face and tongue. 
2.5 Self induced seizures 
It is possible for some children to induce petit mal or grand mal seizures by over breathing, 
watching a blinking light or by performing some other form of learned behavior. In such 
cases drug therapy alone is usually unsatisfactory. Patient by doing so tries to draw 
attention to himself and is usually associated with complex family problems and psychiatric 
consultation is indicated. 
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3. Diagnosis and treatment 
3.1 Diagnosis 
The diagnosis of epilepsy requires the presence of recurrent, unprovoked seizures. Patients 
presenting with seizures should have a general and neurologic examination, looking for 
other causes of loss of consciousness (eg, cardiac abnormalities, evidence of infection), 
contributing factors or secondary causes of epilepsy, and focal neurologic signs. Some of the 
important clinical findings include alterations in consciousness, sensation, motor abilities, 
and reflexes. Detailed accounts of the seizures from either the patient or eyewitnesses can be 
important in making a correct diagnosis.  
Diagnostic tools, such as electroencephalography (EEG) and magnetic resonance imaging 
(MRI), are required to classify epilepsy. EEG records waves generated by the brain cortex. 
These waves have characteristics that allow the differentiation of normal from abnormal 
electrical discharges and provide information about localization. EEG amplifies the waves 
and transfers them to a computer for interpretation (Aragon & Burneo, 2007).  
When diagnosing epilepsy, the underlying disease must be identified. The signs and 
symptoms of the patient before, during, and after the seizure are vital for determining the 
cause. The patient and any witnesses should be questioned, and a physical examination for 
trauma, infections, and other conditions should be completed. Electroencephalography 
studies will often reveal an abnormality, especially when additional stimuli are recorded, 
such as flashing lights, music or rhythmic sounds, sleep deprivation, or hyperventilation. 
The use of blood tests, magnetic resonance imaging, or computed tomography may also 
yield helpful information leading to a diagnosis. Primary epilepsy is often diagnosed by 
exclusion of all other causes (Hupp, 2001). 
3.2 Treatment 
Seizure disorders are generally more severe in people who have mental retardation. Patients 
who have developmental disabilities and epilepsy are treated for their seizure type or types 
and syndrome just like any other person who has epilepsy. Several options exist for the 
treatment of epileptic seizures, including antiseizure medications, vagal nerve stimulation, 
ketogenic diet, and surgery. These options are may be used concurrently in the same 
individual if needed (Robbins, 2009). The choice of medication is related to the type of 
seizure (Table). In some cases, a trial of anti-seizure medication may be used in a patient 
with strong evidence of more than one seizure, whereas a patient with a single seizure is 
usually monitored but not given medication. Long-term therapy using one anticonvulsant 
medication is most desirable, although some patients need a combination to achieve efficacy 
with limited toxicity (Hupp, 2001). The most common oral side effect of antiepileptic drugs 
seen in the dental office is gingival hyperplasia (Fig. 1). Gingival hyperplasia is 
characterized by unusual growth of the gingival subepithelial connective tissue and 
epithelium, for unknown reasons; it is reversed once the drug is discontinued. 
Anticonvulsant drugs such as phenytoin, carbamazepine, valproic acid, and others have 
been used individually and in combinations. They act to reduce the frequency of seizures, 
elevate the seizure threshold of the motor cortex, and limit the spread of the excitation from 
the focus of the seizure (Hupp, 2001). In an epilepsy program, the objective is to find out 
whether the patient is a surgical candidate by using special tests, such as prolonged 
monitoring video-electroencephalography (VEEG) and structural MRI. VEEG allows 
confirmation of epilepsy syndrome and location of the epileptogenic focus. The behavioural 
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changes captured by video and the focal epileptiform abnormalities in the EEG are the most 
important pieces of information in the presurgical evaluation. 
 
Drug Type of seizure Most common oral side effects and 
dental considerations 
Phenytoin GTCS, partial Gingival hyperplasia, delayed healing, 
gingival 
bleeding, osteoporosis 
Carbamazepine GTCS, partial Agranulocytosis, aplastic anemia, 
xerostomia, delayed 
healing, gingival bleeding 
(thrombocytopenia), 
osteoporosis 
Valproic acid Absence, any type Excessive bleeding, decreased platelet 
aggregation, 
delayed healing, osteoporosis, xerostomia, 
stomatitis, gingivitis, drug interactions 
with aspirin 
and nonsteroidal anti-inflammatory drugs 
Phenobarbital Any type Drowsiness, drug interactions, xerostomia, 
stomatitis, 
osteoporosis 
Ethosuximide Absence Leukopenia, Stevens-Johnson syndrome, 
orofacial 
edema, dysgeusia
Primidone Partial (psychomotor) Ataxia, vertigo, stomatitis, osteoporosis 
Gabapentin Partial Xerostomia, stomatitis, gingivitis, glossitis, 
orofacial 
edema, dysgeusia 
Table 1. Adverse effects of antiepileptic drugs commonly used in children. 
Temporal lobectomy is perhaps the most common type of surgery for epilepsy. In the only 
randomized controlled trial of surgery versus medical treatment, the success rate was 64%. 
However, patients can experience a significant decline in verbal memory (McKhann et al., 
2002). Which can be partly predicted through a detailed neuropsychologic evaluation 
(Loring, 1997).  
4. Treating dental patients with epilepsy 
4.1 General situation 
The medical literature contains little information on the influence of epilepsy in dental care. 
Most existing studies focus on phenytoin-induced gingival hyperplasia. These individuals 
often have worse oral health status than the general population. They tend to have a higher 
incidence of dental caries and difficulty in accessing dental care (Chikte et al., 1991). The 
main reason for higher prevalence of dental caries in disabled individuals is the inadequate 
plaque removal. Visually impaired cannot visualize the plaque on the teeth surfaces so even 
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Fig. 1. Severe gingival enlargement in a child with epilepsy. 
understanding the importance of oral hygiene is difficult for them, which results in the 
progression of dental caries as well as inflammatory disease of the periodontium (Mann et 
al., 1984). Patients living with epilepsy have special needs during dental treatment. In 
almost all aspects of oral health and dental status, the condition of patients with epilepsy is 
significantly worse than age-matched groups in the general (nonepileptic) population 
(Karolyhazy et al., 2003). Furthermore, patients who have poorly controlled epilepsy and 
experience frequent generalized tonic–clonic seizures exhibit worse oral health in 
comparison with patients who are better controlled or only have seizures that do not 
involve the masticatory apparatus (Karolyhazy, et al., 2003). 
The number of decayed and missing teeth, the degree of abrasion and periodontal indexes 
are significantly worse in patients with epilepsy. Those with epilepsy also have significantly 
fewer restored and replaced teeth than the general population (Karolyhazy et al., 2005). 
4.2 Dental status and oral health 
4.2.1 Trauma 
Dentofacial trauma occurring during seizures has been reported to include injuries to the 
tongue, buccal mucosa, facial fractures, avulsion, luxation or fractures of teeth, and 
subluxation of the temporomandibular joint (Ogunbodede et al., 1998).  
Generalized tonic–clonic seizures often cause minor oral injuries, such as tongue biting, 
(Pick & Bauer, 2001) but also frequently lead to tooth injuries (Buck et al., 1997), and in some 
cases to maxillofacial trauma (Aragon et al., 2001). 
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Gurbuz et al. (Gurbuz & Tan, 2010) found a traumatic anterior dental injury rate of 68.8% in 
children with epilepsy in Erzurum, Turkey. This probably resulted from insufficient seizure 
control or from placing hard objects between the teeth of patients during seizures. 
According to O’Sullivan, the prevalence of traumatic anterior dental injury was 11–30% in 
children without epilepsy (Curzon, 2001). Generalized tonic–clonic seizures often cause 
minor oral injuries, such as tongue biting, but also frequently lead to tooth injuries (Buck, et 
al., 1997) and in some cases to maxillofacial trauma (Aragon, et al., 2001). 
Patients with epilepsy can be at increased risk of fracture because enzyme-inducing 
antiepileptic drugs (e.g., phenytoin, phenobarbital, carbamazepine) alter the metabolism 
and clearance of vitamin D and have been associated with osteopenia and osteomalacia. Of 
interest, increased fracture risk has also been associated with the use of benzodiazepines, 
antidepressants and antipsychotics, suggesting that underlying brain disease or adverse 
effects of the medication are responsible for falls and injuries  (Mattson & Gidal, 2004). 
Fractures can have catastrophic effects on the lives of patients with epilepsy, and measures 
are available to minimize the risk of fractures, such as ensuring adequate calcium and 
vitamin D supplementation (a minimum of 1,000 mg and 400 IU daily, respectively) 
especially in patients taking phenobarbital, phenytoin or primidone (Sato et al., 2001). 
4.2.2 Periodontal problems 
Children younger than 15 years constitute a large group among epileptic individuals, and a 
considerable proportion of them also have mental and motor deficits (Bourgeois, 1995; 
Brodie & Dichter, 1996). These patients are at risk for oral health due to their poor self-care 
and the side-effects of anticonvulsant treatment: in particular, the use of phenytoin and 
phenobarbital can be associated with gingival enlargement (Delasnerie-Laupretre & Turpin, 
1991; Thomason et al., 1992). Patients with epilepsy can be at increased risk of fracture 
because enzyme-inducing anti-epileptic drugs (AED; e.g., phenytoin, phenobarbital, 
carbamazepine) alter the metabolism and clearance of vitamin D and have been associated 
with osteopenia and osteomalacia (Mattson & Gidal, 2004). The association of phenytoin 
with gingival enlargement was first described by Kimball in 1939 (Kimball, 1939); 
subsequently, many articles have reported on its incidence or severity in different 
populations. The literature reveals a wide variation in its incidence, ranging from 3 to 93%. 
The variability is primarily due to differences in criteria for assessing the severity of the 
hyperplasia, the different sizes and ages of studied groups, and variations in the duration 
and dosage of phenytoin treatment. However, it is now widely accepted that clinically 
significant hyperplasia is seen in about 50% of patients taking phenytoin (Majola et al., 2000; 
Ogunbodede, et al., 1998; Perlik et al., 1995; Thomason, et al., 1992). 
The logical approach in drug-induced gingival enlargement is a reduction of the dose or 
replacement with another drug (Dahllof et al., 1991; Lundstrom et al., 1982; R. A. Seymour et 
al., 1985). 
Because gingival enlargement has not been reported with carbamazepine so far and appears 
to be extremely rare with valproate, these drugs have been proposed as alternatives in the 
treatment of patients who develop or are at risk of phenytoin-induced gingival enlargement 
(R. A. Seymour, et al., 1985).  
Gingival enlargement as a complication of phenytoin use has been well studied 
(Angelopoulos, 1975a, 1975b). About 50% of patients taking this medication will develop 
gingival hyperplasia within 12–24 months of initiation of treatment. Despite the existence of 
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newer medications that are equally effective and have fewer side effects, phenytoin remains 
one of the most commonly used drugs. Evidence regarding best treatment for gingival 
hyperplasia is lacking. Some clinicians advocate the use of chlorhexidine, folic acid rinses or 
both, but excellent oral hygiene will probably prevent or significantly decrease the severity 
of the condition. In severe cases, surgical reduction is needed (Stoopler et al., 2003). 
The newer antiepileptic drugs produce oral manifestations only infrequently. Xerostomia 
and stomatitis have been reported rarely as side effects of carbamazepine, (Ogunbodede, et 
al., 1998) and rash that may involve the oral cavity has been associated with lamotrigine and 
can be exacerbated by the concomitant use of valproic acid (Li et al., 1996).  
Although phenytoin-induced gingival enlargement has been better studied, its pathogenesis 
is still unclear. Several mechanisms related to an interaction between phenytoin and the 
gingival fibroblasts have been hypothesized. Phenytoin decreases cellular folate uptake 
possibly by inhibiting cation currents, leading to local folate deficiency. This results in 
insufficient synthesis of collagenase activator proteins, which play a role in connective tissue 
catabolism. As connective tissue catabolism is limited, gingival enlargement develops 
(Brown et al., 1991). The sensitivity of gingival fibroblasts to phenytoin is different in each 
individual and is genetically determined. This might, in some degree, explain why not all 
phenytoin-treated individuals develop gingival enlargement. Recently, several reports 
revealed that the pathogenesis of phenytoin-induced gingival enlargement might be related 
to certain cytokines, including interleukin-1, -6, and -8; platelet-derived growth factor BB; 
and basic fibroblast growth factor (Hong & Trackman, 2002; Modeer et al., 2000; Sasaki & 
Maita, 1998). Whether similar mechanisms play a role in valproate-induced gingival 
enlargement is unclear.  
Valproic acid can cause direct bone marrow suppression, which can impair wound healing 
and increase post-operative bleeding and infections. Decreased platelet count is the most 
common and best-recognized hematologic effect of valproic acid; the incidence varies from 
5% to 40%. Clinically significant bleeding is uncommon because the thrombocytopenia is 
usually not severe. For elective surgery, laboratory evaluation — including bleeding time, 
fibrinogen level, prothrombin time, partial thromboplastin time and von Willebrand factor 
level — is needed to assess the risk of peri- and postoperative bleeding. Bleeding as a 
potential side effect should be discussed with patients and their families in preparation for 
surgery (Acharya & Bussel, 2000).  
According to Tan et al., VPA can be associated with side-effects in gingival tissue in children 
by a mechanism attributable to the drug rather than oral hygiene or inflammation (Tan et 
al., 2004). 
Those findings are consistent with the present results. Seymour reported that the most 
important determinant of phenytoin-induced gingival enlargement was poor oral hygiene 
(R.A.  Seymour, 1992). 
The pathogenesis of phenytoin-induced gingival enlargement is still not well known but 
several mechanisms, all related to an interaction between phenytoin and the gingival 
fibroblast, have been hypothesized. Valproic acid can cause direct bone marrow suppression, 
which can impair wound healing and increase postoperative bleeding and infections (Aragon 
& Burneo, 2007). The reaction begins as a diffuse swelling of the interdental papillae, which 
enlarge and coalesce. Clinically significant overgrowth occurs in approximately 50% of 
patients (Cameron & Widmer, 2008). The incidence and severity of overgrowth are the greatest 
on the labial surfaces on maxillary and mandibular anterior teeth (Fig. 1). 
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4.2.3 Prosthodontic problems 
Epilepsy is a chronic disease that can affect oral health and prosthodontic status in different 
ways. However, epilepsy is a condition of various etiologies and seizure types, and different 
patients may have differing needs in prosthodontic care (Karolyhazy, et al., 2005). 
In a recent analysis of the prosthodontic status of patients with epilepsy, it was found out 
that compared with age-matched controls, patients with epilepsy have a tendency to become 
edentulous earlier. It was also found that prosthodontic treatment is suboptimal, as 
significantly fewer teeth are replaced, despite the fact that epileptic patients tend to have 
more missing teeth. Based on these findings, the authors suggested a classification for 
patients with epilepsy according to dental risk factors and dental manageability and 
provided recommendations for dental treatment (Aragon & Burneo, 2007). 
Friedlander and Cummings (Friedlander & Cummings, 1989) mentioned that in patients 
with epilepsy replacement of missing teeth is important to prevent the tongue from being 
caught in the edentulous spaces during seizures. 
Specific guidelines were also provided, such as discouragement of incisal restorations, use 
of fixed rather than removable prostheses and inclusion of additional abutments if fixed 
partial dentures are to be used (Karolyhazy, et al., 2005). In addition, the use of metal base 
for complete dentures and telescopic retention with denture bases made of metal or 
reinforced with metal for nearly edentulous patients was recommended for those with 
frequent partial seizures involving the masticatory apparatus, frequent generalized tonic–
clonic seizures and other seizures associated with falls. Patients with epilepsy have an 
increased risk for loosing teeth, and the prosthodontic status of epilepsy patients is not 
optimal. This may unfavorably affect quality of life. 
4.2.4 Orthodontic problems 
Anti-epileptic drugs related to oral findings include recurrent aphthous-like ulcerations, 
gingival bleeding, hypercementosis, root shortening, anomalous tooth development, 
delayed eruption, and cervical lymphadenopathy (Johnstone et al., 1999). 
Of particular interest to the orthodontist is a recent report of facial and body asymmetries 
affecting 41% of patients with partial seizures in the population studied; asymmetries 
included both hemihypertrophy and atrophy (Fong et al., 2003).  
Gingival enlargement may cause delays in permanent teeth eruption and malocclusions in 
children with mixed dentition (Fig. 2). The hypertonicity of the oral musculature has caused 
the protrusion of the anterior teeth and the orthopaedic compression of the maxilla.  
5. Dental management 
Understanding of epilepsy and seizures raises awareness of the disorder’s impact on 
patients’ general medical and psychological health. Dental treatment of patients with 
epilepsy and seizures should be carried out by dentists who are knowledgeable about these 
disorders (Aragon & Burneo, 2007). The medical literature contains little information on the 
influence of epilepsy in dental care. 
Patients who have epilepsy have been shown to have significantly worse dental condition 
than the general population (Karolyhazy, et al., 2003). The disease may affect the dental 
status and oral health of patients in several ways. Patients who have seizure disorders tend 
to have less'than ideal oral health, with higher numbers of decayed and missing teeth. They 
tend to receive less dental treatment, with significantly fewer restored and replaced teeth 
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Fig. 2. Tooth eruption problem in a child with epilepsy. 
than the general population. This situation can be especially true in patients who have 
development disabilities, who may have trouble accessing dental care anyway. The seizures 
themselves can cause injuries to the teeth and dental prostheses. Some of the drugs can 
cause periodontal disease. Specific considerationsfor epileptic patients include the treatment 
of oral soft tissue side effects of medications and damage to the hard and soft tissue of the 
orofacial region secondary to seizure trauma, especially in patients who suffer from poorly 
controlled generalized tonic-clonic seizures (Robbins, 2009). 
Dentists with a thorough knowledge of seizure disorders and the medications used to treat 
them can provide necessary dental and oral health care for those patients. Patients with 
seizure disorders may report a history of fainting or dizzy spells, seizures, or epilepsy, as 
well as medications to treat the seizures. A thorough evaluation of a patient's seizure 
disorder is necessary before initiation of any dental treatment. Important aspects to evaluate 
include the type of seizures, any known cause, frequency, duration, known triggers such as 
stress or bright lights, presence of aura before seizure activity, and history of injuries related 
to effects or drug interactions noted. The drug history can give some indication as to the 
degree of seizure seizures. Drug history should be carefully reviewed and updated at each 
visit, and any potential drug side severity or control (Robbins, 2009). The general goal of 
dental management is the avoidance of a seizure. It is important to know the type of 
epilepsy and any precipitating factors, medications and dosage, compliance and degree of 
seizure control before commencing treatment. In addition, drug interactions with 
anticonvulsants are common and their half-life and blood levels can be increased substantially. 
Consultation with the child's neurologist is essential before commencement of treatment 
(Cameron & Widmer, 2008). Unfortunately, even if the patient has been compliant with the 
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medication, breakthrough seizures can occur. These may be related to fatigue or lack of sleep, 
menstrual cycle, decreased overall health, a missed meal, alcohol use, physical or emotional 
stress, or pain. If the patient typically has an aura, it should be noted so that the dentist or staff 
members can notice any changes and move to protect the patient (Hupp, 2001).  
Other conditions can lead to seizures in the dental office. The most common nonepileptic 
cause is an overdose of local anesthetic. In addition, hypoglycaemia or insulin overdose, 
hypoxia secondary to syncope, cerebrovascular accident or transient ischemic attack, and 
hyperventilation can occur in the dental office. If a patient has a convulsive seizure while 
undergoing dental treatment, stop the procedure and protect the patient from injury. This may 
involve removing any sharp objects from the area, such as handpieces, placing a soft mouth-
prop, and cushioning the patient’s head. It may also be necessary to control or gently restrain 
their arms and legs, keep them from falling out of the dental chair, and loosen any tight 
clothing. As the patient progresses to the postictal phase, maintain the airway because the 
muscles may become flaccid. Check for level of awareness, reassure them, and determine 
whether medical assistance is needed. Patients with partial or absence seizures usually are not 
at significant risk of loss of consciousness; nevertheless, they must be protected from injury. In 
some patients, the dental staff may be unaware that an episode has even occurred. Status 
epilepticus of a convulsive seizure must be treated urgently. Intravenous administration of 
diazepam or midazolam is needed before permanent brain injury occurs. Either drug should 
be titrated to the point at which seizure activity ceases. Basic life support (ie, airway, breathing, 
circulation) should be performed as required, and fluid in the mouth should be suctioned from 
the buccal aspect of the clenched teeth. Nothing should be forced between the teeth at any 
time, because temporomandibular joint injury or fractured teeth could result. Notification of 
emergency medical personnel is needed (Hupp, 2001).  
It is advisable to check that the patient has taken his/her routine medications, has eaten 
normally, is not excessively tired, and has not been recently ill before starting dental 
treatment. Stress and fatigue are factors that can trigger a seizure. If the patient is not feeling 
well or is overly tired, it may be prudent to reschedule the appointment. Appointments 
should be scheduled during a time of day when seizures are less likely to occur, if 
predictable, and stress and anxiety should be minimized. Explaining the dental procedures 
to the patient before starting, and offering assurance during the procedure may be helpful. 
The use of nitrous oxide or conscious sedation may be necessary to provide dental care 
safely and effectively. In patients whose seizure disorder is poorly controlled and whose 
developmental disabilities make the delivery of dental care difficult, general anesthesia may 
need to be considered. General anaesthesia is preferable in children with poor seizure 
control as the abnormal neural activity is completely ablated during the procedure. Dental 
trauma is an obvious consequence in the child with frequent, poorly controlled seizures. 
Removable appliances are contraindicated in an epileptic child due to potential airway 
obstruction (Cameron & Widmer, 2008). Light can be a trigger in inducing an epileptic 
seizure. Dark glasses used as eye protection and careful positioning of the dental light so 
that it is directed into the mouth and not flashed in the patient's eyes can minimize any 
problems (Robbins, 2009). 
It is well known that phenytoin causes gingival hyperplasia in a majority of patients. Studies 
have reported that the drug induces fibroblasts and osteoblasts, that there is an excessive 
deposition of extracellular matrix, and that normal tissue turnover and wound healing are 
altered. The most common sites for hyperplasia are the labial aspects of the maxillary and 
mandibular ridges. The tissue has normal color and surface texture, with lobular shape of 
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the interdental papillae and a firm, resilient feel, often without inflammation. Local irritants 
make the response more exuberant in some patients, with the typical erythema, edema, and 
easy bleeding of common gingivitis. If significant hyperplasia leads to discomfort, inability 
to function, or esthetic concerns, surgical reduction is necessary. The anterior labial surfaces 
of the maxillary and mandibular gingiva are the most commonly affected (Fig. 1) and it is 
strongly correlated with poor plaque control. It is believed that excellent oral hygiene will 
prevent or reduce the gingival response to phenytoin.  
Most convulsive disorders are controlled through medication and pose few problems in 
dental treatment. It should be made sure that the child has taken the daily dose of 
medicines. Since anxiety is a frequent precipitation factor, premedication with minor 
tranquilizers will be effective. These children often arrive at the dental office in 
a slightly sedated state due to the CNS depressed activity of anticonvulsant medications. 
Use of mouth props is mandatory during treatment because once the seizure begins; it is 
difficult to insert any device to prevent intraoral injury due to clenching of the jaws. If 
appliances are indicated for tooth movement or tooth replacement purposes, fixed appliance 
is preferred because there is less chance of dislodgement (Rao, 2008). Generalized tonic-
clonic seizures often cause minor oral injuries such as tongue biting and tooth injuries. 
Traumatic injury to anterior teeth should be evaluated in the standard way. Fractures of the 
anterior teeth can be repaired with composite restorations. A chest radiograph may be 
indicated if a tooth is avulsed and cannot be accounted for. Soft tissue wounds should be 
explored for tooth fragments when incisal fractures occur. Patients who have epilepsy can 
also be at increased risk for maxillofacial fractures caused by drugs-induced osteoporosis 
(Turner & Glickman, 2005). 
The coarsening of facial features in patients on phenytoin is related to the increased activity 
of osteoblasts. Other intraoral side effects are seen with anticonvulsant medications, 
especially in the first few weeks of therapy. A rash or erythema multiforme may develop 
that can manifest in the mouth as erosions and ulcerations. Phenytoin has been associated 
with aphthous ulcers. Some of the medications (ie, carbamazepine, phenytoin, 
phenobarbital) affect bone marrow function, which can lead to altered immune response, 
thrombocytopenia, and bleeding. Valproic acid inhibits platelet aggregation. Others affect 
liver function (ethosuximide, carbamazepine), which impairs coagulation. If signs of 
petechial hemorrhage or abnormal bleeding are noted, hemostasis should be evaluated 
before surgical treatment. Drug interactions should also be considered for patients on 
anticonvulsants. A patient taking barbiturates (eg, primidone, phenobarbital) should avoid 
any other central nervous system depressants such as narcotics or nitrous oxide. Anti-
epileptic drugs can cause xerostomia, which can put patients at increased risk for 
developing caries, especially in the cervical region and candidiasis. In children, increased 
dental caries can also be seen if drugs are delivered in a syrup form. Carbamazepine can 
cause ulcerations, xerostomia, glossitis, and stomatitis.  The frequency of dental check-ups 
and prophylaxis appointments should be based on the patient's needs. The recall and 
hygiene interval may be more frequent for epileptic patients because of increased risk for 
gingival hyperplasia secondary to use of an anti-epileptic drug. Patients who are xerostomic 
should be put on supplemental topical fluoride to prevent dental decay and monitored 
regularly for candidal infections. The importance of good oral hygiene should be stressed to 
the patient and caregivers (if appropriate) (Robbins, 2009). Aspirin carbamazepine increase 
liver microsomal enzyme activity, decreasing the activity of concurrent, nonsteroidal anti-
inflammatory medications, and the antifungal fluconazole will increase the blood level of 
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phenytoin and add to the platelet effects of valproic acid. Propoxyphene and erythromycin 
interfere with the metabolism of carbamazepine, which can lead to toxic levels of the 
anticonvulsant (Hupp, 2001). Thereafter, patients on VPA should be educated on oral 
hygiene and their oral health should carefully be followed. Gingivectomy is the treatment of 
choice in case of gingival hyperplasia that usually occurs with phenytoin therapy. They 
usually tend to reccur. Hence the drug or the dose can be modified upon consultation with 
the paediatrician. 
The presence of a seizure disorder can influence prosthodontic treatment decisions. Missing 
teeth should be replaced to prevent the tongue from being caught in the edentulous space 
and injured. Treatment planning considerations must consider fabrication of dental 
prostheses designed to minimize the risk for displacement of teeth or further damage. Fixed 
prostheses or implants are preferable to removable appliances because the latter can 
dislodge during a seizure and cause oral injury or airway obstruction. Large posterior 
restorations are prone to fracture in someone who may have jaw spasms during a tonic-
clonic seizure. All-metal units should be considered whenever aesthetically possible, to 
minimize the chance of porcelain fracture. In the anterior, metal crowns with acrylic or 
composite facings can be used to facilitate repair as needed. For fixed partial dentures, the 
use of additional abutments may be advisable for more stability. If removable partial 
prostheses are unavoidable, they should be constructed with metallic palates and bases 
instead of acrylic and metal backings to anterior denture teeth (Robbins, 2009). 
The danger of injury to the teeth and prostheses during this type of seizure is the highest 
and should be considered when designing dental prostheses. For occlusal restorations, the 
use of ceramic inlays is best avoided; complete metal-ceramic crowns are recommended 
instead. Generally, fixed rather than removable prostheses are preferred. For fixed partial 
dentures, the use of additional abutments may be advisable for more stability. If removable 
partial dentures are unavoidable, the dentures should be designed with a large metal base. 
As more teeth are lost, telescopic retention may be advised with a base made of metal or 
reinforced with metal. The base of complete dentures should also be metal or reinforced 
with metal, because an acrylic base may fracture, increasing the risk of aspiration or 
dislodgement into the esophagus. A small number of patients with epilepsy, primarily those 
where the disease is associated with inborn or perinatal encephalopathy, have a severe 
mental handicap that precludes cooperation. In these patients, general anesthesia is usually 
necessary to perform dental treatment, and prosthodontic rehabilitation is usually not 
performed. Seizure-related injuries to prostheses are also an issue, but only for those who 
are refractory to treatment and suffer from frequent generalized tonic-clonic seizures. 
Therefore, the large majority of patients can and should receive prosthodontic treatment 
without restrictions. In a smaller portion of patients, however, certain restrictions apply to 
prevent potentially dangerous seizure-related complications (Karolyhazy, et al., 2005). 
Patients with epilepsy and a malocclusion should have a comprehensive orthodontic 
evaluation. It is important for the orthodontist to be alert to dental or facial trauma that may 
have previously occurred during seizures. The level of orthodontic intervention must take 
into account the type of seizure disorder and efficacy of control. History related by the 
patient should be confirmed during a discussion with the patient’s physician. Adverse side 
effects of drugs and past dental trauma should be researched by the orthodontist and 
reviewed as part of patient informed consent. Mechanical challenges such as closing 
interdental spaces in the presence of gingival hypertrophy should be considered when 
estimating treatment time. One patient did have a tonic-clonic seizure during fixed 
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orthodontic treatment and suffered laceration of the lip mucosa and luxation of maxillary 
incisors; the patient’s mother believed that the orthodontic appliance prevented incisor 
avulsion during the seizure. Accepting such risks should be decision of the patient and/or the 
guardian after careful discussion with the orthodontist. The metal in a fixed orthodontic 
appliance may distort images obtained by magnetic resonance imaging (MRI). Any metal 
portions of the orthodontic appliance close to the area being scanned decreases MRI quality. In 
some patients, an acceptable MRI may be obtained if arch wires and other removable 
components are removed before the scan; others will require the removal of the entire 
orthodontic appliance. This author treated one patient who required yearly MRI brain 
imaging. The patient’s orthodontic treatment was impacted in the following way: fixed 
appliances were placed the day after MRI scan; 12 months into treatment, all appliances were 
removed; the MRI was obtained, and appliances were replaced. The fixed appliance was 
removed after 23 months of therapy, just before the next scheduled MRI scan (Sheller, 2004). 
5.1 Management of the epileptic patient in the dental office 
It is the responsibility of every dentist to have emergency procedures planned and 
rehearsed with their office staff on a regular basis. The dentist should reduce stress of the 
child by behavioral management and conscious sedation techniques. Reduce direct 
overhead lighting, particularly for the photosensitive form of epilepsy. Avoid seizure-
promoting medications such as CNS stimulants and local anaesthetics containing adrenaline 
(epinephrine). Emergency drugs such as oxygen, intravenous or rectal diazepam (Valium) 
and intravenous phenobarbital sodium should be readily available. Take a complete health 
history and a complete seizure history. List all medications, including side effects and 
potential drug interactions (Gingival hyperplasia and bleeding tendencies in patients taking 
drug). Minimize risk for damaging or displacing restorations or prostheses during seizure.  
The dentist should be careful while positioning of dental light and avoide of known 
precipitating factors. Consider use of mouth prop at the beginning of procedure. If a seizure 
occurs while a patient is in the dental chair. Firstly, clear all instruments away from the patient. 
Place the dental chair in a supported, supine position as near to the floor as possible. Place the 
patient on his or her side (to decrease the chance of aspiration of secretions or dental materials 
in the patient’s mouth). If possible, remove any foreign material from mouth. If possible, turn 
patient onto his/her side. Passively restrain only to prevent patient from falling out of chair or 
hitting nearby objects. After the seizure, it is better to discontinue the therapy. If a cavity is 
already prepared, either temporize or complete the final restoration. Time the seizure (the 
duration of the event may seem longer than it actually is). After seizure, turn patient to the 
side to avoid aspiration and examine for traumatic injuries. If seizure last more than 3 minutes 
or patient become cyanotic. Administer oxygen at a rate of 6–8 L/minute. If the seizure lasts 
longer than 1 minute or for repeated seizures, administer a 10-mg dose of diazepam 
intramuscularly (IM) or intravenously (IV), or 2 mg of ativan, IV or IM, or 5 mg of midazolam, 
IM or IV. Be aware of the possibility of compromised airway or uncontrollable seizure. Also, 
contact the patient’s family, if he or she is alone (Aragon & Burneo, 2007; Rao, 2008; Robbins, 
2009). 
6. Conclusion 
The oral conditions observed demonstrate the need for dentists to follow up and treat these 
children. In addition, there is an ongoing need to improve the oral hygiene of these 
www.intechopen.com
 
Novel Aspects on Epilepsy 
 
170 
individuals to prevent the development of periodontal and dental disease in later life. 
Advances in diagnostic technology, pharmacotherapy and understanding of neurologic 
processes allow dentists to understand and manage patients with epilepsy better. People 
with epilepsy can be safely treated in a general dental practice. A thorough medical history 
should be taken and updated at each visit. Seizure history must be taken into account when 
planning treatment. Dentists with a comprehension of seizure disorders can provide an 
invaluable service to their patients, providing not only oral health, but also maintaining and 
promoting the systemic health of these patients. Patients who have developmental 
disabilities and epilepsy can be safely treated in a general dental practice. Most patients who 
have epilepsy can and should receive functionally and esthetically adequate dental care. 
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